Combinostics has developed a leading technology platform by applying AI to MRI — providing data-driven decision support for doctors worldwide. It makes it possible to detect patients suffering from neurodegenerative diseases, such as dementia and Alzhemier’s, earlier and intervene adequately to delay the progression of the disease.